Find out how you, like Sue, can enjoy a 'big advantage'
In 1984, having suddenly lost her hearing to Meningococcal Meningitis, Sue Walters put her faith in ‘groundbreaking’ new hearing technology - the Cochlear™ Nucleus® 22 implant. In the decades that followed, Sue received a second implant on her other ear and upgraded her sound processors many times.
Now that she has access to the Nucleus 7 Sound Processor for both ears, Sue has experienced the differences from her previous devices that have made a real impact on her everyday living.
‘As I get older, my hearing is getting better!’
Find out why Sue is excited about being able to stream phone and conference calls, podcasts and music directly to both her sound processors, and how ForwardFocus^ is a ‘big advantage’ that ‘just helps you so much in background noise’.
More information
Disclaimer
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
For a full list of Cochlear’s trademarks, please visit our Terms of Use page.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.